Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Lab Notes: Larimar plans $70M stock sale, gets FDA clearance to resume clinical testing By: Philadelphia Business Journal via Business Journals September 16, 2022 at 11:35 AM EDT A Villanova-based biotech startup focus on heart disease gets a new CEO Read More >> Related Stocks: Harbor Disruptive Innovation ETF Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Lab Notes: Larimar plans $70M stock sale, gets FDA clearance to resume clinical testing By: Philadelphia Business Journal via Business Journals September 16, 2022 at 11:35 AM EDT A Villanova-based biotech startup focus on heart disease gets a new CEO Read More >> Related Stocks: Harbor Disruptive Innovation ETF